BIO-ELECTRONIC ONCOLOGY

Transforming Surgical Precision Through Advanced Bio-Electronic Technology.

Our proprietary bio-electronics technology powered by advanced impedance-based sensing to detect subtle physiological and morphological changes occurring within cells. Coosa Technologies equips surgeons delivers precise, timely clinical information with accurate data for better clinical decision-making to enhanced surgical outcomes, and improved patient care.

Explore Platform Systems Explore R&D Journey

Pioneering Bio-Electronic Precision to Reduce Diagnostic Latency in Oncology

We engineer real-time, cellular-level diagnostic and therapeutic platforms that empower surgeons and oncologists at the point of care. By converging bio-electronic sensing, catalytic nanotechnology, and electrochemical detection, Coosa transforms surgical precision while helping preserve healthy tissue.

THE CLINICAL BREAKTHROUGH

Redefining Margin Assessment in Breast-Conserving Surgery

When pathology results arrive days after surgery, patients can face the emotional and clinical trauma of a second operation. Coosa’s Cancer Diagnostic Probe (CDP) brings the decision into the operating room by analyzing catalytic Reactive Oxygen Species (ROS) and cellular metabolic markers with multi-wall carbon nanotube micro-sensor arrays.

The result is actionable intraoperative margin verification in seconds—before the wound is closed, and without compromising the specimen for definitive pathology.

TARGET: NON-DESTRUCTIVE MARGIN EVALUATIONCalibrated 2.1 mm sampling depth engineered to preserve tissue architecture for standard FFPE histopathology.
ASEPTIC SURGICAL INTEGRATIONSterile, single-use disposable probe tips engineered for rapid turnover in surgical suites.
POINT-OF-CARETelemetry readout is generated in under 15 seconds directly in the operating field.
An Expanding Ecosystem
CDP

Cancer Diagnostic Probe

Intraoperative ROS/H₂O₂ margin assessment.

TND

ThyroNode Detector

Point-of-care thyroid nodule profiling.

GIS

Gastro-Intestinal Screening

Endoscopic early-stage lesion screening.

CXS

Cervi-Xpectra System

Non-invasive cervical dysplasia detection.

CHS

Cool Hemostasis System

The Cool Hemostasis System (CHS) is an active therapeutic medical device intended for controlled hemostasis and bleeding control during surgical procedures.

ENGINEERING TRUSTClinical-grade design intent

Our catalytic sensing arrays and electrode based interfaces are developed within an ISO 13485-aligned quality management track with technical documentation aligned to CE Mark frameworks.

CORPORATE IDENTITYCIN: U74999DL2023PTC409808

Incorporated under the Ministry of Corporate Affairs in New Delhi and recognized as an innovator at Startup Mahakumbh.

Honors & Validation

Recognized for Pioneering Diagnostic Innovation in Surgical Oncology

Coosa Technologies brings together deep-tech innovation, validated clinical performance, and global intellectual property standards to move critical surgical decisions closer to the point of care.

01

National Recognition & Deep-Tech Honors

Coosa Technologies has been recognized on premier national innovation platforms, celebrating breakthrough deep-tech engineering and translational biomedical achievements.

  • 🏆
    🏆 NATIONAL DEEP-TECH HONOUR Winner – Startup Mahakumbh 2.0

    Recognized for pioneering innovation in deep-tech medical engineering at Bharat Mandapam and Yashobhoomi Convention Centre, New Delhi.

  • 🏷
    GOVT OF INDIA • DPIIT Registered under DPIIT Start-up India

    Formally recognized and registered under DPIIT Start-up India, Ministry of Commerce & Industry, Government of India.

Startup Mahakumbh 2.0 Winner Trophy
Startup Mahakumbh 2.0 Winner Award
02

Regulatory Milestones & Clearances

Stringent pre-market evaluations, statutory manufacturing licensures, and multi-site clinical trial authorizations anchor our regulatory trajectory.

  • ☑
    MULTI-SITE CLINICAL TRIAL Multi-Site Clinical Trial Permission (CDP)

    Obtained clinical trial permission for the Cancer Diagnostic Probe (CDP) across multi-site centers in the Delhi/NCR region.

  • 📜
    SMDI SCHEME CLEARANCE SMDI Scheme Clinical Project Approval

    Received clinical trial project approval under the Scheme for Promotion of Medical Device Industry (SMDI) for indigenous medical device acceleration.

CDSCO manufacturing approval graphic
CDSCO Manufacturing Approval
03

Quality & Compliance Management

Medical device quality governance aligned with global regulatory frameworks, verified cleanroom protocols, and NABL-accredited test validation.

  • ✓
    ISO 13485:2016 QUALITY SYSTEM ISO 13485 Quality Management System

    Implementation of a medical device quality management system is underway to support ISO 13485 certification, ensuring strict design controls and safety verification.

  • ⚙
    NABL-ACCREDITED LAB TESTING NABL-Accredited Testing

    Device design verification and validation (V&V) activities conducted systematically through NABL-accredited testing laboratories.

  • 🔍
    ISO CLASS 7/8 CLEANROOM Controlled Cleanroom Manufacturing

    Manufacturing operations governed by cleanroom protocols and calibrated testing instruments for precision bio-electronic sensor integrity.

ISO 13485:2016 Certificate
ISO 13485:2016 Quality Management
04

Commercial Readiness & Supply Network

A growing hospital-facing supply network supports dependable delivery of instruments and sterile consumables across critical clinical care centers.

  • 🤝
    CLINICAL CHANNEL NETWORK Collaborated with Authorized Partners

    Established strategic partnerships with verified clinical channel partners to support regional institutional delivery and support.

  • 🏥
    HOSPITAL-FACING LOGISTICS Institutional Distribution Network

    Hospital-facing supply infrastructure supporting surgical suites, comprehensive cancer institutes, and ambulatory diagnostic centers.

  • 🔬
    GAMMA-STERILE PROBE PIPELINE Single-Use Sterile Probe Tip Pipeline

    Dedicated production pipeline for single-use, gamma-sterilized probe tips preventing cross-contamination and preserving specimen integrity.

Facility Transit and Supply Network
Logistics & Institutional Supply Corridor
CHRONOLOGICAL PROGRESSION

Corporate Milestones & Key Achievements (2023 – 2026)

The structured progression of Coosa Technologies from early incorporation to clinical trial permissions, DPIIT registration, CDSCO approvals, and national deep-tech awards.

2023 Phase 01

Company Incorporation

Incorporated on 11 January 2023 in the Delhi-NCR region, with a vision to develop advanced biomedical diagnostic technologies.

FOUNDATION
2024 Phase 02

R&D and Clinical Development

Initiated cancer diagnostic technology development and obtained clinical trial permission for the Cancer Diagnostic Probe (CDP) at Multi-site in Delhi/NCR region.

CLINICAL TRIAL PERMISSION
2025 Phase 03

Manufacturing and Quality

Initiated medical device manufacturing facility development, design verification and validation, and implementation of an ISO 13485-aligned quality management system.

ISO 13485 QMS TRACK
2026 Phase 04

Recognized by DPIIT

Registered under DPIIT Start-up India, receiving official recognition from the Ministry of Commerce & Industry, Government of India.

DPIIT REGISTERED
2026 Phase 05

Clinical Project Approval

Received clinical trial project approval under the Scheme for Promotion of Medical Device Industry (SMDI) for indigenous medical device acceleration.

SMDI SCHEME
2026 🏆 Phase 06 • Honour

Winner of Startup MahaKumbh 2.0

Coosa Technologies was recognized as a winner at Startup Mahakumbh 2.0, held at Yashobhoomi Convention Centre, New Delhi, for its innovation in deep-tech medical engineering.

🏆 APEX NATIONAL WINNER
OFFICIAL CREDENTIALS & ACCOLADES

Recognitions & Certifications

Verified documentation, national award honors, statutory manufacturing licenses, and international quality certifications.

Startup Mahakumbh 2.0 Winner Award Trophy
🏆 NATIONAL HONOUR • 2026

Startup Mahakumbh 2.0 Winner

Awarded at Yashobhoomi & Bharat Mandapam, New Delhi for excellence in deep-tech medical engineering.

ISO 13485:2016 Quality Management Certificate
ISO 13485:2016 QUALITY

Medical Device Quality System

QMS for the design, verification, and manufacture of bio-electronic medical instruments.

DPIIT Startup India Certificate of Recognition
GOVERNMENT OF INDIA

DPIIT Startup India Certificate

Registered and recognized startup under Ministry of Commerce & Industry, Government of India.

CDSCO manufacturing approval graphic
STATUTORY REGULATORY

CDSCO Manufacturing Approval

Regulatory authorization for medical device manufacturing under applicable medical device rules.

Phase 01 · Macro

A Single Contact

The point where surgical oncology meets cellular biophysics. The CDP probe makes non-destructive contact with the surgical cavity bed.

Phase 02 · Micro

The Metabolic Frontier

Diving past the calibrated 2.1 mm threshold. Neoplastic cells excrete elevated Reactive Oxygen Species (ROS) and H₂O₂ into the extracellular space.

Phase 03 · Nano

Catalytic Telemetry

MWCNT micro-sensor arrays capture radical gradients, converting biochemical activity into real-time electrical telemetry in under 15 seconds.

Phase 04 · Return

Clean Margin Verification

Actionable intraoperative guidance before wound closure—preserving tissue architecture for gold-standard FFPE pathology.

SURGICAL ONCOLOGYFaster margin decisions

Intraoperative sensing supports cavity and nodal assessment before closure.

DIAGNOSTIC RADIOLOGYClearer lesion stratification

Probe-based scoring complements ultrasound guidance for ambiguous lesions.

PATHOLOGY & LABSPreserved specimens

Rapid triage leaves tissue architecture available for definitive pathology.

HOSPITAL OPERATIONSMore predictable workflows

Point-of-care information can support OR scheduling and reduce avoidable delays.

Facility & Infrastructure

Our Facility

World-class medical device infrastructure, integrated quality control laboratories, and ISO 13485:2016 certified systems engineered for clinical precision.

COOSA TECHNOLOGIES PRIVATE LIMITED is a trusted leader at the forefront of cancer care and surgical innovation, empowering healthcare professionals with advanced bio-electronic technologies and delivering excellence in healthcare solutions.

“Transforming Surgical Precision Through Advanced Bio-Electronic Technology”

Our Facility · Gurugram, Haryana

Our facility is based at A-06, First Floor, Info City-01, Sector 34, Gurugram, Haryana 122002, India. This has been achieved by installing world-class infrastructure, facility, and reliable technology for medical products.

COOSA TECHNOLOGIES PRIVATE LIMITED has a world-class construction designed by a team of professionals who have combined the art of equipment with the concept of medical device industry Quality Systems, Environmental conditions, and advanced cleanroom standards.

Salient Features of the Facility

FEATURE 01 ✓

Controlled Environment Facility

Equipped with micro-filtered positive air-pressure cleanroom suites meeting stringent ISO particulate classes.

FEATURE 02 ✓

Fully Integrated QC Lab

Complete in-house testing for sensor sensitivity, bio-impedance calibration, and electrochemical integrity.

FEATURE 03 ✓

Facility ISO 13485:2016 Requirement

Engineered and audited in strict conformance to medical device quality management standard ISO 13485:2016.

FEATURE 04 ✓

Unidirectional Flow of Men & Materials

Architectural airlocks and single-direction transition corridors eliminate any potential cross-contamination.

FEATURE 05 ✓

Ventilation System Designed for GMP

Multi-stage HEPA filtration, calibrated air changes per hour (ACPH), and continuous differential pressure monitoring.

Coosa office interior COOSA OFFICE

Our Office

A look inside the Coosa Gurugram facility.

Coosa office workspace COOSA OFFICE

Our Workspace

Office space at the Coosa Gurugram facility.

Quality Assurance & Quality Control Systems

COOSA TECHNOLOGIES PRIVATE LIMITED, with an eye towards quality, implemented the Quality Management System conforming to ISO Standards & it is certified on ISO 13485:2016. Our top priority is given to quality culture and customer satisfaction, making continued efforts to maintain the highest quality standards.

Quality Assurance and Quality Control Departments ensure the quality of the product at all stages of processing to finished goods. The highest quality standards are achieved through a well-documented Quality Manual, Quality System Procedures, and other standard operating procedures, which are harmonious with ISO 13485:2016.

This has been achieved by installing world-class infrastructure and reliable technology for medical products.

High-Precision Microscopic Sensor Array Quality Control
IN-PROCESS MICRO-INSPECTION · CATALYTIC SENSOR ARRAY

Accreditations, Regulatory Licences & Certifications

Verified regulatory compliances and institutional certifications upholding medical device safety, efficacy, and quality management.

ISO 13485:2016 Certificate GLOBAL STANDARD
MTIC INTERCERT / IAF

ISO 13485:2016

Medical devices Quality Management System for design, development, and manufacturing of bio-electronic surgical diagnostic systems.

CDSCO manufacturing approval graphic STATUTORY APPROVAL
CDSCO / STATE LICENSING AUTH.

CDSCO Manufacturing Approval

Regulatory authorization for medical device manufacturing under applicable medical device rules.

DPIIT Startup India Certificate of Recognition GOVT. OF INDIA
DPIIT · MINISTRY OF COMMERCE

Startup India Recognition

Certificate of Recognition as an innovative healthcare & medical technology enterprise under the flagship Startup India initiative.

Facility Route Map and Transit Directions - Gurgaon, Haryana
Diagrammatic Route Map & Transit Corridor

Facility Coordinates & Transit Access

Our Facility:
A-06, First Floor, Info City-01, Sector 34,
Gurugram, Haryana 122002, India

Transit Highlights:

  • 📍 Sector 34, Gurugram, Haryana 122002, India.
  • 🗺️ Use Google Maps for current directions and transit options.
Clinical Oncology Suite

Flagship Diagnostic Platform

A bio-electronic platform for intraoperative margin and lymph-node assessment during breast-conserving surgery.

01
Intraoperative verification Margin & nodule assessment
Coosa CDP Intraoperative Margin Assessment Probe
INTRAOPERATIVE SURGICAL SUITE
Intraoperative Surgical Probe

Cancer Diagnostic Probe (CDP)

Under Clinical Evaluation Adjunctive Intraoperative Tool

Real-Time Margin & Lymph Node Assessment

CDP is used inside lumpectomy cavities and on regional axillary lymph nodes during breast-conserving surgery. Its catalytic array reads metabolic ROS and H₂O₂ activity in under 15 seconds while preserving specimen architecture for pathology.

ROSMetabolic signal readout
REAL-TIMECavity interrogation
STERILESingle-use probe tips
AXILLARYNodal assessment pathway
Clinical scope & technology

Clinical indications

  • Cavity-side margin verification
  • Axillary lymph-node assessment
  • Incidental mass interrogation
  • Single-use sterile headprobe exchange

Core capability

Functionalized multi-walled carbon nanotube arrays are designed to generate a calibrated micro-amperometric readout at a 2.1 mm contact depth within a sterile workflow architecture.

Clinical Intelligence

Latest Research and Articles

Follow the clinical questions and bio-electronic research themes shaping Coosa's diagnostic platforms.

Histopathology scan
Oncology Insight

Differentiating Bilateral Fibrocystic Changes from Early Micro-Malignancies

A clinical perspective on separating benign structural changes from early molecular signals that warrant closer diagnostic review.

Explore diagnostic platforms →
Endocrine tissue
Endocrine Axis

Thyroid Dysregulation & Dense Fibroglandular Tissue Profiling

Examining how endocrine context can inform tissue characterization in radiologically dense breast tissue.

Read the R&D approach →
Metabolic cellular pathway
Bio-Energetics

Hormone Shifts & Extracellular Radical Release

Exploring the relationship between benign epithelial metabolism and extracellular redox activity.

View the sensing journey →
Biochemical redox assay
Research Digest

Methylxanthine Intake & Cellular Redox Dynamics

A research digest on breast density, cellular redox behavior, and the signals that guide future platform development.

Meet Coosa Meditech →
Operating Room Integration

Clinical Care Pathway

Follow the diagnostic sequence through intraoperative verification, pathology correlation, and the next generation of Coosa platforms.

Active OR Protocol

Three-Stage Surgical Workflow

LIVE SURGICAL TELEMETRY
STAGE 01 • ONCOPLASTIC SURGERY

Targeted Lumpectomy Tumor Excision

The surgical team carries out lumpectomy resection following standard oncologic protocols. The excised specimen and surgical margins remain untouched by destructive dyes or cryo-freezing, ensuring pristine structural integrity.

Procedure: Lumpectomy Technique: Oncoplastic Resection Specimen Status: Untouched
LIVE SURGICAL TELEMETRY
CAVITY EXPOSURE: READY
PREPARING CDP IN-VIVO PROBE
R&D Pipeline

Multi-Organ Oncology Roadmap

4 Indications in Active Pipeline
Endocrinology Prototyping

ThyroNode (TND)

Bio-electronic fine-needle interrogation for indeterminate thyroid nodules under sonography guidance.

STAGE 03 / 04 PROTOTYPING
Gynecology Optimization

Cervi-Xpectra (CXS)

Objective spectral bio-sensing for cervical dysplasia, bypassing visual colposcopy subjectivity.

STAGE 02 / 04 OPTIMIZATION
Gastroenterology In-Vitro

GI Screening (GIS)

Endoscopic probe integration for mucosal margin discrimination during direct lesion resection.

STAGE 02 / 04 IN-VITRO
Surgical Hemostasis Pre-Clinical

Cool Hemostasis System

Active therapeutic medical device intended for controlled hemostasis and bleeding control during surgical procedures.

STAGE 03 / 04 PRE-CLINICAL
DIRECT COMMUNICATION

Contact Us

Get in touch directly with our team for institutional evaluations, clinical collaborations, and partnership discussions.

OFFICIAL EMAIL ID info@coosa.in

For institutional communications, clinical protocols, and general business correspondence.

Send Email
CONTACT NUMBER +91 9311922937

Direct phone line for quick assistance, clinical inquiries, and partnership desk.

Call +91 9311922937